Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in PLoS Genet

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    January 2021
  1. BAIRD DA, Liu JZ, Zheng J, Sieberts SK, et al
    Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    PLoS Genet. 2021;17:e1009224.
    PubMed     Abstract available


    September 2020
  2. YUAN J, Xing H, Lamy AL, Lencz T, et al
    Leveraging correlations between variants in polygenic risk scores to detect heterogeneity in GWAS cohorts.
    PLoS Genet. 2020;16:e1009015.
    PubMed     Abstract available


    July 2020
  3. BRETHERICK AD, Canela-Xandri O, Joshi PK, Clark DW, et al
    Linking protein to phenotype with Mendelian Randomization detects 38 proteins with causal roles in human diseases and traits.
    PLoS Genet. 2020;16:e1008785.
    PubMed     Abstract available


    May 2020
  4. LEPPERT B, Millard LAC, Riglin L, Davey Smith G, et al
    A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
    PLoS Genet. 2020;16:e1008185.
    PubMed     Abstract available


    April 2020
  5. MAURER GW, Malita A, Nagy S, Koyama T, et al
    Analysis of genes within the schizophrenia-linked 22q11.2 deletion identifies interaction of night owl/LZTR1 and NF1 in GABAergic sleep control.
    PLoS Genet. 2020;16:e1008727.
    PubMed     Abstract available


    March 2019
  6. SUN R, Hui S, Bader GD, Lin X, et al
    Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic.
    PLoS Genet. 2019;15:e1007530.
    PubMed     Abstract available


    December 2018
  7. NAGY S, Maurer GW, Hentze JL, Rose M, et al
    AMPK signaling linked to the schizophrenia-associated 1q21.1 deletion is required for neuronal and sleep maintenance.
    PLoS Genet. 2018;14:e1007623.
    PubMed     Abstract available


  8. TOMA C, Pierce KD, Shaw AD, Heath A, et al
    Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.
    PLoS Genet. 2018;14:e1007535.
    PubMed     Abstract available


    August 2018
  9. BHALALA OG, Nath AP, Inouye M, Sibley CR, et al
    Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue.
    PLoS Genet. 2018;14:e1007607.
    PubMed     Abstract available


    July 2018
  10. WHITTON L, Apostolova G, Rieder D, Dechant G, et al
    Genes regulated by SATB2 during neurodevelopment contribute to schizophrenia and educational attainment.
    PLoS Genet. 2018;14:e1007515.
    PubMed     Abstract available


    February 2017
  11. POLIMANTI R, Gelernter J
    Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder.
    PLoS Genet. 2017;13:e1006618.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: